Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

Albini, 1996, The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells, Nat. Med., 2, 1371, 10.1038/nm1296-1371 Albini, 1998, Identification of a novel domain of HIV tat involved in monocyte chemotaxis, J. Biol. Chem., 273, 15895, 10.1074/jbc.273.26.15895 Benelli, 1998, Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides, AIDS, 12, 261, 10.1097/00002030-199803000-00003 Borgatti, 1997, Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells, Eur. J. Immunol., 11, 2805, 10.1002/eji.1830271110 Cafaro, 1999, Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine, Nat. Med., 6, 643, 10.1038/10695 Caputo, 1999, Multiple functions of human immunodeficiency virus type 1 Tat protein in the pathogenesis of AIDS, Recent Res. Dev. Virol., 1, 753 Cohen, 1999, Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge, Proc. Natl. Acad. Sci. USA, 19, 10842, 10.1073/pnas.96.19.10842 Conant, 1996, Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes, J. Virol., 70, 1384, 10.1128/JVI.70.3.1384-1389.1996 Demirhan, 1999, Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 4, 364, 10.1097/00126334-199912010-00007 Ensoli, 1993, Release uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation, J. Virol., 1, 277, 10.1128/JVI.67.1.277-287.1993 Frankel, 1998, HIV-1, fifteen proteins and an RNA, Annu. Rev. Biochem., 67, 1, 10.1146/annurev.biochem.67.1.1 Gallo, 1999, Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine, Proc. Natl. Acad. Sci. USA, 15, 8324, 10.1073/pnas.96.15.8324 Gibellini, 1997, Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein, Blood, 89, 1654, 10.1182/blood.V89.5.1654 Gibellini, 1998, Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells, J. Immunol., 160, 3891, 10.4049/jimmunol.160.8.3891 Gibellini, 2000, Extracellular HIV-1 Tat protein activates the transcriptional reprossor ICER in both Jurkat cell line and primary peripheral blood mononuclear cells, AIDS, 14, 1059, 10.1097/00002030-200005260-00019 Gringeri, 1998, Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients, J. Hum. Virol., 1, 293 Gringeri, 1999, Tat toxoid as a component of a preventive vaccine in seronegative subjects, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 4, 371, 10.1097/00042560-199904010-00007 Jones, 1994, Control of RNA initiation and elongation at the HIV-1 promoter, Annu. Rev. Biochem., 63, 717, 10.1146/annurev.bi.63.070194.003441 Karn, 1999, Tackling Tat. J. Mol. Biol., 293, 235, 10.1006/jmbi.1999.3060 Kiernan, 1999, HIV-1 Tat transcriptional activity is regulated by acetylation, EMBO J., 18, 6106, 10.1093/emboj/18.21.6106 Kumar, 1998, HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1, J. Immunol., 161, 776, 10.4049/jimmunol.161.2.776 Lafrenie, 1996, HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes, J. Immunol., 157, 974, 10.4049/jimmunol.157.3.974 Le Buanec, 1998, prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid, Biomed. Pharmacother., 52, 431, 10.1016/S0753-3322(99)80020-1 Li, 1995, Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein, Science, 5209, 429, 10.1126/science.7716549 McCloskey, 1997, Dual role of HIV Tat in regulation of apoptosis in T cells, J. Immunol., 158, 1014, 10.4049/jimmunol.158.2.1014 Marzio, 1998, HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter, Proc. Natl. Acad. Sci. USA, 95, 13519, 10.1073/pnas.95.23.13519 Meyerhans, 1989, Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations, Cell, 58, 901, 10.1016/0092-8674(89)90942-2 Milani, 1998, HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells, AIDS, 12, 1275, 10.1097/00002030-199811000-00008 Mitola, 1997, Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1, Blood, 90, 1365, 10.1182/blood.V90.4.1365 Ott, 1999, Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity, Curr. Biol., 30, 1489, 10.1016/S0960-9822(00)80120-7 Ramazzotti, 1996, Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein, AIDS, 5, 455, 10.1097/00002030-199605000-00002 Re, 1995, Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 10, 408, 10.1097/00042560-199512000-00003 Re, 1996, Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients, Clin. Diagn. Lab. Immunol., 3, 230, 10.1128/CDLI.3.2.230-232.1996 Re, 2000, Viral load trend in HIV-1 seropositive patients with different CD4 cell count before strarting HAART, J. Clin. Virol., 17, 5, 10.1016/S1386-6532(00)00064-0 Rubartelli, 1998, HIV-I Tat, a polypeptide for all seasons, Immunol. Today, 12, 543, 10.1016/S0167-5699(98)01351-6 Steinaa, 1994, Antibody to HIV-1 Tat protein inhibits the replication of virus in culture, Arch. Virol., 139, 263, 10.1007/BF01310790 Wang, 1999, Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein, Virology, 257, 502, 10.1006/viro.1999.9688 Westendorp, 1995, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature, 375, 497, 10.1038/375497a0 Zagury, 1998, Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS a rationale for the use of Tat toxoid as an HIV-1 vaccine, J. Hum. Virol., 1, 282 Zauli, 1993, Human immunodeficiency virus type 1 Tat protein protects lymphoid epithelial and neuronal cell lines from death by apoptosis, Cancer Res., 19, 4481 Zauli, 1995, An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 10, 306, 10.1097/00042560-199511000-00002 Zauli, 1995, The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells, Blood, 86, 3823, 10.1182/blood.V86.10.3823.bloodjournal86103823 Zauli, 1996, Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation induction of apoptosis and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes, J. Immunol., 5, 2216, 10.4049/jimmunol.157.5.2216